A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants
Trial details
- Registry ID
- NCT06720038
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy InfantsNCT06720038 | PCVX | Phase 2 | Active not recruiting | 2027-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |